Raymond J. Henley Iii

Array ( [id] => 3409887 [patent_doc_number] => 05443848 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Hypertonic isochloremic formulations for treatment of hypovolemic and circulatory shock' [patent_app_type] => 1 [patent_app_number] => 8/126242 [patent_app_country] => US [patent_app_date] => 1993-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10171 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/443/05443848.pdf [firstpage_image] =>[orig_patent_app_number] => 126242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3112812 [patent_doc_number] => 05395822 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-07 [patent_title] => 'Use of pyruvate to prevent neuronal degeneration associated with ischemia' [patent_app_type] => 1 [patent_app_number] => 8/124348 [patent_app_country] => US [patent_app_date] => 1993-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8402 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/395/05395822.pdf [firstpage_image] =>[orig_patent_app_number] => 124348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586289 [patent_doc_number] => 05496567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-05 [patent_title] => 'Composition having buffering and nutritional properties' [patent_app_type] => 1 [patent_app_number] => 8/112768 [patent_app_country] => US [patent_app_date] => 1993-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2864 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/496/05496567.pdf [firstpage_image] =>[orig_patent_app_number] => 112768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3418084 [patent_doc_number] => 05434142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-18 [patent_title] => 'Method of treatment for muscular dystrophy' [patent_app_type] => 1 [patent_app_number] => 8/111119 [patent_app_country] => US [patent_app_date] => 1993-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2328 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/434/05434142.pdf [firstpage_image] =>[orig_patent_app_number] => 111119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2998109 [patent_doc_number] => 05358969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Method of inhibiting nitric oxide formation' [patent_app_type] => 1 [patent_app_number] => 8/110915 [patent_app_country] => US [patent_app_date] => 1993-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 6009 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/358/05358969.pdf [firstpage_image] =>[orig_patent_app_number] => 110915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3001211 [patent_doc_number] => 05371109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-06 [patent_title] => 'Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase' [patent_app_type] => 1 [patent_app_number] => 8/107908 [patent_app_country] => US [patent_app_date] => 1993-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2545 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/371/05371109.pdf [firstpage_image] =>[orig_patent_app_number] => 107908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3407835 [patent_doc_number] => 05460835 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-24 [patent_title] => 'Aluminum salts in the treatment of bone disease' [patent_app_type] => 1 [patent_app_number] => 8/106791 [patent_app_country] => US [patent_app_date] => 1993-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 8881 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/460/05460835.pdf [firstpage_image] =>[orig_patent_app_number] => 106791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3027999 [patent_doc_number] => 05348957 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-20 [patent_title] => '5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents' [patent_app_type] => 1 [patent_app_number] => 8/103462 [patent_app_country] => US [patent_app_date] => 1993-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8710 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 516 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/348/05348957.pdf [firstpage_image] =>[orig_patent_app_number] => 103462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3496731 [patent_doc_number] => 05532239 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Therapeutic application of fluoroquinolone derivatives' [patent_app_type] => 1 [patent_app_number] => 8/100799 [patent_app_country] => US [patent_app_date] => 1993-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1513 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532239.pdf [firstpage_image] =>[orig_patent_app_number] => 100799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590727 [patent_doc_number] => 05487893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-30 [patent_title] => 'Antiviral use of a 2,6-di-t-butylphenol compound substituted in 4 position against herpes viruses and papillomaviruses' [patent_app_type] => 1 [patent_app_number] => 8/050279 [patent_app_country] => US [patent_app_date] => 1993-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8759 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/487/05487893.pdf [firstpage_image] =>[orig_patent_app_number] => 050279 [rel_patent_id] =>[rel_patent_doc_number] =>)